Risk for Mortality Higher Based on Wildfire PM2.5 Than Total PM2.5

Follow Drugslib on

By Elana Gotkine HealthDay Reporter

Medically reviewed by Carmen Pope, BPharm. Last updated on Aug 26, 2025.

via HealthDay

TUESDAY, Aug. 26, 2025 -- On a global scale, relative risk for mortality associated with wildfire fine particulate matter (PM2.5) is greater than for total PM2.5, according to a study published online Aug. 13 in The Lancet Planetary Health.

Anna Alari, Ph.D., from ISGlobal in Barcelona, Spain, and colleagues obtained daily mortality records in 654 contiguous subnational regions from 32 European countries to examine the association between wildfire-related PM2.5 and mortality. These data were combined with daily estimates of fire-related and non-fire-related PM2.5.

The study included 95.3, 19.5, and 3.9 million daily deaths for all-cause mortality, cardiovascular mortality, and respiratory mortality, respectively, from Jan. 1, 2004, until the latest available year in each country. Pooled cumulative relative risks associated with a 1-µg per m3 increase in fire-related PM2.5 were 1.007 (95 percent confidence interval [CI], 1.004 to 1.010), 1.009 (95 percent CI, 1.006 to 1.013), and 1.013 (95 percent CI, 1.008 to 1.019) for all-cause, cardiovascular, and respiratory mortality, respectively. Compared with non-fire-related PM2.5, relative risks were larger for fire-related PM2.5. Fire-related PM2.5-attributable mortality was underestimated by 93 percent with use of relative risks for total PM2.5 (fire-related and non-fire-related).

"Human-driven climate change is one of the main causes of the rising frequency and intensity of wildfires, as it creates favorable conditions for their spread and increases the number of days with very high or extremely high fire risk," Alari said in a statement. "Improving estimates of PM2.5-related wildfire mortality will help better track the burden of this climate change-related threat to public health."

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2025-08-27 06:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords